
Photo by Innerbody Research
Probably everyone who has lived past 30 has reckoned with what it means to age. That’s typically when people begin to see firsthand evidence that aging isn’t just the passing of time but also the accumulation of mental and physical changes, big and small. Each age-related change you experience begins at the cellular level, and it can be addressed likewise.
In roughly the past 20 years, a coenzyme called nicotinamide adenine dinucleotide (NAD) has gained the spotlight as a linchpin in the cellular aging process. If you can maintain your stores of NAD as you grow older, you may be able to stave off some of those diseases we normally associate with senescence — heart disease, cancer, and neurodegeneration, for example.
The challenge is that NAD levels naturally decline over time, and maintenance isn’t a simple matter of taking an NAD pill. Instead, the most effective and accessible way to prevent NAD level decline is to exploit the biological processes that cause the body to make NAD in the first place. That is, you take an NAD precursor, like nicotinamide mononucleotide (NMN).
In this guide, we take you on a close-quarters tour through NAD and NMN, explaining what exactly they are, how they relate to each other, and why NMN is the superior supplement option between them. By the end, you ought to have the knowledge you need to make an informed health decision that may help you extend your lifespan while looking and feeling like a younger version of yourself.
As a supplement, NAD’s poor oral bioavailability means it will do little to increase your NAD+ levels.14 To get any significant effect from straight NAD administration, it would have to be delivered by IV infusion, which is very time-consuming and costly. NMN, on the other hand, has excellent oral bioavailability and easily converts to NAD+ inside your body. Furthermore, it may provide other health benefits on its own, with studies showing that it can suppress age-related weight gain, increase insulin sensitivity, and improve eye function. To learn more, visit our full guide to NMN supplements or learn more about our top recommendation below.
This supplement delivers a combined 1100mg of NMN and NR, the two precursors that boost NAD+.
With 700mg of NMN and 400mg of NR, this supplement uniquely aligns with a broad body of clinical research, compared to its competitors. Beyond that, NAD+ Support stands out by providing supportive ingredients in TMG, spermidine, and black pepper extract, which can improve bioavailability and help deliver a more sustained, positive impact from supplementing with the NAD+ precursors. Independent third-party test results confirms its purity, and subscribing brings deep discounts.
NAD refers to nicotinamide adenine dinucleotide. It’s an umbrella term for two coenzymes, or molecules that assist enzymes in carrying out their biochemical reactions. There’s NAD+, the oxidized form, and NADH (NAD with hydrogen), the reduced form. Both are essential to key biochemical processes, including glycolysis, by which cells produce energy. The science of oxidation and reduction (redox) reactions can be a lot to digest, but as it relates to NAD, we can simplify it like this:1
So, why is it that NAD+, and not NADH, is the star subject of recent longevity studies? Two reasons, mainly:
NAD+ is concentrated in the mitochondria, which generate most of our cellular energy and are implicated in processes associated with DNA repair, cellular senescence, and the immune system.2 NAD+ directly supports mitochondrial function by regulating mechanisms related to reactive oxygen species (ROS).3 If left unchecked, ROS can degrade the mitochondria and damage macromolecules such as DNA, in turn spurring the onset of age-related pathologies such as diabetes, fatty liver disease, heart disease, cancer, and neurodegeneration (e.g., Alzheimer’s, Parkinson’s).4
At the same time that NAD+ is snatching electrons, your enzyme systems are actively consuming NAD+, so the balance between it and NADH becomes dysregulated over time.5 Because redox balance is central to maintaining proper fundamental biological functions (e.g., respiration, metabolism), this dysregulation can contribute to those above-mentioned disease pathologies we typically associate with aging.6
The sum of it is this: redox balance and healthy mitochondria help stave off the effects of aging, and you need sufficient stores of NAD+ to have both.
NAD+ occurs naturally in the body via three pathways, along with a cast of biological actors variably comprising:
| Type | Role | |
|---|---|---|
| Nicotinamide mononucleotide (NMN) | NAD+ precursor | Converts to NAD+ in the body |
| Nicotinamide riboside (NR) | NAD+ precursor (a form of B3) | Converts to NMN |
| Niacinamide (NAM, a.k.a. nicotinamide) | Another form of B3 | Converts to NMN |
| Nicotinic acid mononucleotide (NAMN) | An intermediate in NAD+ biosynthesis | Converts to NAD+ |
| Nicotinic acid (NA) | NAD+ precursor (a form of B3) | Converts to NAMN |
| Tryptophan | Essential amino acid | Metabolizes into quinolinic acid, which converts to NAMN |
Here’s a more detailed breakdown of how they play out in their respective roles:
The salvage pathway is the primary route of endogenous NAD+ production, generating around 85% of the body’s total.7 Here, NAM and NR both convert to NMN (with NR entering from a different angle). The NMN then converts to NAD+. Your cells can subsequently use the NAD+ generated through the salvage pathway and cycle leftover NAM back to the beginning. Under ideal conditions, it’s like a donut shop: using some of the unfried dough to make yet more donuts.
Named after the researchers who first described it in 1958, the Preiss-Handler pathway goes from NA to NAMN, and then NAMN to NAD+. Because of NA’s tendency to cause flushing (a warming rush of blood to the face), it may be a less-than-ideal NAD+ precursor for many potential users.8
Rather than B3, the de novo synthesis pathway starts with the amino acid tryptophan, which metabolizes into quinolinic acid, which in turn converts to NAMN. From there, NAMN becomes NAD+ à la the Preiss-Handler pathway. While de novo circumvents NA and its associated flushing, you should know that tryptophan, in high enough quantities, can have its own side effects: tremor, nausea, and dizziness.9
Notice that catalyzing actors in the Preiss-Handler and de novo synthesis pathways — NA and tryptophan, respectively — both can cause undesirable effects on their own. NMN, one of the precursors in the salvage pathway, is less prone to causing such or similar risks.

Photo by Innerbody Research
Although your body produces NAD+ by multiple cyclical pathways, remember that NAD+ levels decline with age, and unless you restore your levels, you leave your mitochondria in a vulnerable state and your body more susceptible to the diseases we’ve mentioned.10
You have a few options for restoring your levels.
You could go to a clinic for an NAD+ infusion, in which a medical practitioner hooks you up to an IV drip that delivers the coenzyme directly into your bloodstream. This therapy can significantly increase your plasma NAD+ levels for a sustained period, but you have to be patient. You’ll need no less than two hours, with a needle in your arm to see the desired increases, and sessions can last even longer than that.11 They’re pricey, too, ranging from $250 to $1,500 per infusion, according to the Vaccine Alliance.12
NAD+ injections are a less time- and cost-intensive alternative. Rather than hours of IV infusion, you get a quick intramuscular stick with a needle syringe. This can be done at a clinic or at home; depending on which treatment pathway you choose, an injection can cost as little as $25 and as much as $200.12 But for all that, the effects aren’t all that long-lasting, so you may need to receive a fresh injection every 1-2 weeks, if not several times per week.13 The cost quickly adds up. Moreover, most of the supportive research for direct NAD+ administration to the blood has relied on infusion, so dose recommendations for injections are less clear.
The third option, an NAD+ boosting supplement, is the most economical, and therefore the most sustainable for the broadest population of people. The concern, though, is bioavailability. Taken orally, most of the NAD+ in a supplement will degrade in the digestive tract and ultimately fail to increase your levels.14 But the same cannot be said for NAD+ precursors. Both NMN and NR are absorbed well and quite rapidly through digestion, and either one would be a solid pick for an NAD+ boosting supplement.15
But if you had to pick just one, know that NMN boasts a few qualities, unreplicated thus far with other precursors, that might help you decide whether it’s better aligned with your health goals than NR.
Nicotinamide mononucleotide (NMN) is one of the main NAD+ precursors in the body. Most of our NMN is synthesized from a form of B3 called niacinamide (NAM).16 The conversion of NAM to NMN relies on a type of molecule called a methyl donor, of which your body has a finite “pool” from which to draw for diverse biochemical processes.17 From there, the NMN converts to NAD+.
As a supplement, NMN is much more orally bioavailable than NAD+.18 That, coupled with the fact that it’s just one step removed from becoming NAD+ in the salvage pathway — as opposed to NR, which must first be converted to NMN — means it’s theoretically the best choice for an NAD+ booster.
We referred earlier to the qualities of NMN that so far have yet to be replicated by other precursors, such as NR. Specifically, in clinical research, NMN has demonstrated the ability to suppress age-related weight gain, improve insulin sensitivity, and improve eye function, none of which NR has demonstrated to date.16 To be sure, NR is linked to a separate health benefit that NMN is not: specifically, it has been shown to decrease biomarkers of neurodegeneration by itself.19
Apart from the risk of an allergic reaction — which practically any supplemental, medical, or dietary substance can cause — NMN and NAD pose little to no danger in the short term.
With NAD, the most likely effects are mild. An oral NAD supplement, at high enough doses, might upset your stomach, give you gas, or make you feel bloated; and as an IV infusion or intramuscular injection, it might cause an injection site reaction, other local skin irritation, and significant nausea. In rare cases, high-dose NAD therapy may lead to kidney dysfunction or an electrolyte imbalance, typically when there’s a preexisting condition at play.20
As for NMN, oral supplementation has yielded no serious adverse events in clinical settings, even with doses up to 1,200mg per day.21 22 But we should reiterate that these are short-term findings. Over time, with consistent supplementation, NMN could theoretically give you cause for concern.
The theoretical health risks in question are downstream effects related to the process by which your body makes NAD+. To recap:
The second and third points in the above process are of key concern, as they contribute to one of two potential adverse effects:
Note that (a) you need a steady supply of methyl donors for the salvage pathway to work properly, and (b) cellular NAD+ usage leaves NAM as a by-product.23 But your pool of methyl donors is finite. If you don’t top off your supply, you don’t have the fuel needed to convert NAM to NMN, and you end up with excess NAM that other players can take toward their own ends. Take, for example, the digestive enzyme nicotinamide N-methyltransferase (NNMT), which converts NAM to methylnicotinamide.32 Methylnicotinamide, for its part, can lead to mitochondrial dysfunction, in turn contributing to the pathogenesis of insulin resistance, coronary artery disease, and Parkinson’s24 — effectively, the opposite of what you’d want from your NAD+ boosting efforts.
Therefore, if you supplement with NMN, you’ll also want to take a methyl donor such as trimethylglycine (TMG, a.k.a. betaine) or something like spermidine, which helps increase levels of a methyl donor called S-adenosyl methionine synthase.25
The theory goes that since NAD+ improves cellular function and efficiency, it would do the same for cancer cells. A 2021 study published in Aging Medicine says as much, stating that “NAD ... [has] already been implicated in various cancers, as cancer requires vast energy to proliferate.”26 The authors go on to say that “starving cancer of NAD and from the enzymes found in the myriad of NAD pathways may ... hold merit in the fight against slowing further cancer progression.”26
To be clear, none of this establishes a direct link between NAD+ and cancer progression; rather, it’s a deduction by correlation based on the observation that cancer cells don’t thrive in the absence of NAD+. Still, if you have an active cancer diagnosis or a history of cancer (personal or familial), you might be better off without an NMN or other NAD+ boosting supplement.
NMN’s legal status isn’t exactly a safety issue, but it’s at least safety-adjacent and worth discussing here.
In 2022, the U.S. Food & Drug Administration (FDA) announced the prohibition of NMN for sale as a dietary supplement. This wasn’t due to any newly discovered health risks but to the fact that NMN was being studied as an Investigational New Drug (IND). Consequently, NMN’s designation as a legal supplement was thrown into limbo, because:
In response, the Natural Products Association filed a lawsuit against the FDA based on the fact that NMN had been sold as a supplement long before the start of its IND-related studies. Then, in 2024, a federal court issued a motion to suspend legal proceedings on the case.29 The suspension effectively allowed NMN to continue being sold on the market as a supplement.
NMN’s high oral bioavailability makes it superior to NAD as a supplement. Even NAD enhanced with bioavailability-enhancing encapsulation (e.g., liposomal) isn’t likely to have as desirable an impact as NMN.
The more pertinent question, then, is this: How do you choose an NMN supplement?
| Good NMN supplement | Great NMN supplement | |
|---|---|---|
| Dose of NMN | At least 300mg | 600mg or more |
| Supporting ingredients | None | Methyl donors and by-product boosters |
| Other precursors? | No |
The chief thing to look at is the dose. Quantities as low as 300mg have been shown to be effective, but NMN is relatively dose-dependent, so you’d do well to focus your search on products that offer at least 600mg per serving.30 31
Ideally, too, you want the NMN not as a standalone supplement but as part of a complex that includes ingredients that help populate your methyl pool, either directly or by boosting by-products in NAD+ metabolism. Otherwise, your NAD+ levels may rise for a few weeks only to plateau and then decline once your methyl groups have been depleted. Supporting players like TMG and spermidine (at minimum doses of 500mg and 15mg, respectively) can prevent plateaus and declines from happening.
Lastly, an optional but highly recommended addition to your NMN supplement would be nicotinamide riboside (NR), the other principal precursor in the salvage pathway. Although NR’s role in the pathway is to become NMN, it also penetrates cells through a separate entry point, potentially increasing the efficiency of your NAD+ production (think of two work teams constructing separate ends of a wall and converging in the middle). Furthermore, it provides its own health benefits, namely the ability to prevent the onset of neurodegenerative pathologies such as Alzheimer’s.
Sources
Innerbody uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Xie, N., Zhang, et al. (2020). NAD+ metabolism: Pathophysiologic mechanisms and therapeutic potential. Signal Transduction and Targeted Therapy, 5(1), 1-37.
Covarrubias, A. J., et al. (2020). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews. Molecular Cell Biology, 22(2), 119-141.
Yusri, K., et al. (2025). The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. NPJ Metabolic Health and Disease, 3(1), 1-25.
Babbar, M., et al. (2020). Mitophagy and DNA damage signaling in human aging. Mechanisms of Ageing and Development, 186, 111207.
Conlon, N. J. (2021). The role of NAD+ in regenerative medicine. Plastic and Reconstructive Surgery, 150(4 Suppl), 41S-48S.
Franco, R., & Vargas, M. R. (2018). Redox biology in neurological function, dysfunction, and aging. Antioxidants & Redox Signaling, 28(18), 1583-1586.
Su, M., et al. (2024). Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function. Frontiers in Cell and Developmental Biology, 12, 1464815.
Kamanna, V. S., Ganji, S. H., & Kashyap, M. L. (2009). The mechanism and mitigation of niacin-induced flushing. International Journal of Clinical Practice, 63(9), 1369-1377.
Fernstrom, J. D. (2012). Effects and side effects associated with the non-nutritional use of tryptophan by humans. The Journal of Nutrition, 142(12), 2236S-2244S.
Schultz, M. B., & Sinclair, D. A. (2016). Why NAD+ declines during aging: It’s destroyed. Cell Metabolism, 23(6), 965-966.
Grant, R., et al. (2019). A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6-hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11, 481212.
Gerrity, M. (2025). Cost of NAD injections in 2025. Vaccine Alliance.
Dan. (2025). How often should you get NAD Injections? Vaccine Alliance.
Poljšak, B., et al. (2022). Current uncertainties and future challenges regarding NAD+ boosting strategies. Antioxidants, 11(9), 1637.
Yoshino, J., Baur, J. A., & Imai, S. (2018). NAD+ intermediates: The biology and therapeutic potential of NMN and NR. Cell Metabolism, 27(3), 513-528.
Shade, C. (2020). The science behind NMN — a stable, reliable NAD+ activator and anti-aging molecule. Integrative Medicine: A Clinician's Journal, 19(1), 12-14.
Xie, N., et al. (2020). NAD+ metabolism: Pathophysiologic mechanisms and therapeutic potential. Signal Transduction and Targeted Therapy, 5(1), 1-37.
Okabe, K., et al. (2022). Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects. Frontiers in Nutrition, 9, 868640.
Vreones, M., et al. (2022). Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin. Aging Cell, 22(1), e13754.
Sedeek, N. (2025). NAD side effects and safety. Vaccine Alliance.
Freeberg, K. A., et al. (2023). Dietary supplementation with NAD+-boosting compounds in humans: Current knowledge and future directions. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 78(12), 2435-2448.
Liao, B., et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: A randomized, double-blind study. Journal of the International Society of Sports Nutrition, 18, 54.
Nadeeshani, H., et al. (2022). Nicotinamide mononucleotide (NMN) as an anti-aging health product — promises and safety concerns. Journal of Advanced Research, 37, 267-278.
Hwang, E. S., & Song, S. B. (2020). Possible adverse effects of high-dose nicotinamide: Mechanisms and safety assessment. Biomolecules, 10(5), 687.
Vaccaro, J. A., & Naser, S. A. (2021). The role of methyl donors of the methionine cycle in gastrointestinal infection and inflammation. Healthcare, 10(1), 61.
Palmer, R. D., & Vaccarezza, M. (2021). Nicotinamide adenine dinucleotide and the sirtuins caution: Pro‐cancer functions. Aging Medicine, 4(4), 337-344.
National Institutes of Health Office of Dietary Supplements. (1994). Dietary Supplement Health and Education Act of 1994 — Public Law 103-417, 103rd Congress. National Institutes of Health.
National Institutes of Health Clinical Center. (n.d.). What is an IND? National Institutes of Health.
Natural Products Association. (2024). NPA wins huge legal victory against FDA on NMN. NPA.
Mills, K. F., et al. (2016). Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metabolism, 24(6), 795-806.
Yi, L., et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience, 45, 29-43.
Roberti, A., Fernández, A. F., & Fraga, M. F. (2021). Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation. Molecular Metabolism, 45, 101165.